Baum Hedlund Aristei & Goldman changed its name to Wisner Baum in January 2023.

Abilify Gambling & Compulsive Behavior Lawsuit

Abilify Gambling & Compulsive Behavior Lawsuit

We are no longer accepting new Abilify cases

The product liability attorneys at Baum Hedlund Aristei & Goldman are currently reviewing and accepting potential Abilify gambling cases throughout the United States. If you were prescribed Abilify and suffered serious financial loss as a result of compulsive gambling, you may be entitled to compensation through an Abilify gambling lawsuit.

The U.S. Food and Drug Administration (FDA) has issued an Abilify warning, affirming that use of the drug has been associated with impulse control problems, such as gambling, hyperactive sexuality and compulsive shopping. These impulse control issues reportedly stopped when individuals ceased taking Abilify.

One particular Abilify side effect—gambling addiction—can have a devastating impact on your family, your career and your quality of life. Abilify gambling issues have affected a number of individuals who were unaware that research has linked the drug to compulsive or uncontrollable gambling urges.

Read Abilify Gambling Updates

Our firm believes that Bristol-Myers Squibb and Otsuka Pharmaceutical Company, the manufacturers of Abilify, failed to adequately warn consumers about the potential risk/side effect of compulsive gambling. As such, financial compensation may be available to those who suffered financial damages as a result of compulsive gambling while taking Abilify.

Baum Hedlund Aristei & Goldman is offering free, no obligation Abilify case evaluations for individuals across the nation to determine what legal options are available to them and their families. If you are interested in speaking with a product liability attorney about filing an Abilify gambling lawsuit, fill out the form below or call us toll free at 800-827-0087.

We are here to help and can answer any questions you have related to your Abilify gambling claim. While Abilify has been linked to a number of other compulsive behaviors, our firm is only accepting cases related to Abilify gambling issues.


How Does Abilify Work?

This question is difficult to answer because the FDA—which is responsible for assuring the safety, efficacy and security of the drugs we take—says it is “unknown” exactly how Abilify works.

PLOS Medicine critiqued advertising for Abilify, which at one point claimed that the drug works “like a thermostat to restore balance.” The drugmakers widely disseminated this ad campaign to consumers, even though the FDA-approved product information insert for Abilify lists the mechanism of action for aripiprazole as “unknown.”

According to PLOS, this type of advertising “is only possible in the absence of vigorous government regulation or outcry from professional associations. We hypothesize that their combined silence significantly contributes to the process of disease mongering.”

Otsuka America, the company that markets Abilify in the U.S., pointed to two six-week studies to demonstrate that Abilify works better than a placebo in treating major depressive disorder. The problem is that these studies fail to explain how it is that the drug works, only that it works better than a placebo.

It is believed that Abilify (aripiprazole) acts as a ‘partial agonist’ at the serotonin and dopamine receptors, which regulate mood and behavior. Unlike other drugs in the second generation antipsychotics (SAG) class, Abilify does not block dopamine or serotonin receptors. Rather, the drug is supposed to serve two purposes: it can enhance dopamine and serotonin signaling where those transmitters are deficient and it can also inhibit signaling where they are in excess.

When a person’s dopamine system is stimulated, they feel pleasure or a high. This reward system ensures that we continue to do things necessary for survival, like eating, for example. But certain people can have excessively stimulated or blunted dopamine systems. This dysregulation is implicated in schizophrenia, bipolar disorder, depression and ADD.

Abilify Gambling

Joanna Moncrieff, a leading British psychiatrist and author, has argued that antipsychotics like Abilify (aripiprazole) do not actually treat anything—they just zone people out so their awareness is dull. They can be effective for some, but that is essentially because they are powerful tranquilizers.

This appears to be at the heart of the Abilify gambling issue: researchers think Abilify may overstimulate dopamine receptors for some people, triggering compulsive behavior like gambling, hyperactive sexuality and compulsive shopping.

This compulsion can be uncontrollable, driving some people with no prior history of gambling to do so by any means necessary, even when they can no longer afford it. A number of documented cases include people funding their gambling addiction via credit cards or borrowed money. Other severe Abilify gambling cases include individuals who felt they needed to gamble in order to continue living.

This particular Abilify side effect may not result in physical harm to a person, but it can cause serious financial, emotional and psychological problems that tear lives apart.

Those whose lives have been turned upside down due to crippling gambling debt after taking Abilify may have the option of filing an Abilify lawsuit against Bristol-Myers Squibb and Otsuka Pharmaceutical Company, in order to seek compensation.

Abilify Gambling Studies

A number of Abilify studies have found a link between aripiprazole and compulsive gambling:

A 2013 French study examined eight individuals who checked into a clinic to treat pathological gambling. The patients were mostly young men who were schizophrenic or bipolar. Each had a prior history of addictive disorders and regular gambling before they were prescribed aripiprazole. For each, the causality of aripiprazole was considered using an algorithm. According to the study, the probability that pathological gambling was actually due to aripiprazole was considered “possible” in seven of the eight cases. After discontinuing the drug or greatly reducing the dose, most patients regained control of their compulsive behaviors, researchers wrote.

A 2011 case study published by Current Drug Safety found similar results among patients who were being treated for schizophrenia. None of the patients involved with this study had a history of pathological gambling. Soon after they began taking Abilify, they began gambling uncontrollably.

Another 2011 study conducted by the National Problem Gambling Clinic affirmed a relationship between Abilify and gambling. One of the patients involved in the study that was on Abilify, was described by researchers thusly:

“He was pre-occupied with thoughts of gambling and his gambling activity became both impulsive and involved extensive planning in obtaining funds to gamble, including the use of crime.”

Another patient on Abilify described an increase in his gambling “to the extent of spending all of his money and it being ‘a reason to live’.”

In all cases, patients involved in the study reported a positive response in their psychotic symptoms. However, they also reported noticeable changes in their approach to gambling after being prescribed Abilify, experiencing strong compulsions to gamble that differed from reports of other gamblers. Each patient also reported a clear change in their thinking and behavior after they ceased taking the drug. They returned to a more recognizable state of occasional gambling urges that were easier to control.

Another 2010 study published in the Australian & New Zealand Journal of Psychologychronicled the story of a woman who took Abilify to treat schizophrenia. She gambled away thousands of dollars and gained nearly 20 pounds in six months. She had no prior history of gambling or compulsive eating.

Abilify FDA Warning

In May of 2016, the FDA announced that it will require Bristol-Myers Squibb to add new warnings to the Abilify (aripiprazole) label about the increased risk of compulsive gambling and other compulsive behavior.

“Although pathological gambling is listed as a reported side effect in the current aripiprazole drug labels, this description does not entirely reflect the nature of the impulse-control risk that we identified.” – FDA Safety Alert on Abilify, May 2016

According to the FDA, the rare, but serious, impulse control problems cease after an individual stops taking Abilify. The FDA recommended that health care professionals make patients and caregivers aware of the risk of uncontrollable urges when prescribing Abilify. Specifically, doctors should ask patients about any new or increasing urges while they are being treated with aripiprazole and closely monitor for new or worsening compulsive urges in patients at higher risk for impulse-control problems.

Why File an Abilify Gambling Lawsuit?

Bristol-Myers Squibb and Otsuka Pharmaceutical Company had an obligation to inform the public about harmful side effects associated with Abilify. In this case, both companies failed to inform consumers about the compulsive behaviors associated with Abilify.

Abilify’s label makes no mention of compulsive gambling. As a result, patients taking the drug are unknowingly being exposed to serious risk, while Abilify sales continue to bring in billions for Bristol-Myers and Otsuka.

How Do I File an Abilify Lawsuit?

Baum Hedlund Aristei & Goldman is prepared to file cases on behalf of individuals who suffered serious gambling losses while taking Abilify. To find out if you may be eligible to file an Abilify lawsuit, follow these three easy steps:

  • Contact an Abilify Attorney at Baum Hedlund Aristei & Goldman – You can learn more about filing an Abilify gambling lawsuit by calling us toll free at 800-827-0087, or you can fill out the case review form on this page.
  • An Attorney Will Provide You With a Free No Obligation Case Consultation – During this free case consultation, our attorneys will review the circumstances of your claim and determine if you are eligible to seek compensation by filing an Abilify lawsuit. During this time, we can answer any questions you may have related to your claim.
  • Decide Whether Filing an Abilify Lawsuit is the Right Decision For You and Your Loved Ones – Talk to your family about whether filing an Abilify lawsuit is right for you. Even after we review your case and agree to represent you in your Abilify lawsuit, you are under no obligation to file a claim. You decide whether or not to proceed.

About Baum Hedlund Aristei & Goldman

The national law firm of Baum Hedlund Aristei & Goldman has litigated thousands of personal injury, wrongful death and class action lawsuits against major pharmaceutical companies. Our attorneys have been on the prevailing side of some of the most highly publicized cases in the country.

Baum Hedlund has successfully won over $4 billion in verdicts and settlements on our clients’ behalf. With decades of experience handling wrongful death and personal injury cases, we have developed a reputation for holding Fortune 500 companies accountable, influencing public policy, improving product safety and raising public awareness.

Our firm is listed in The Best Lawyers in America, the Bar Register of Preeminent Lawyers, and it maintains the highest AV® peer review legal rating* and is nationally recognized as a preeminent plaintiff firm that tries or settles serious personal injury and wrongful death lawsuits.

For more information about our firm, check out our some of our settlements and verdicts or read some client testimonials.

Abilify News

Related Articles

Contact Us Today

No Fees Unless We Win
  • Please enter your first name.
  • Please enter your last name.
  • +1
    Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please enter your city.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter a message.
  • Paxil Pediatric Class Action $63 Million Settlement

    $63 million pediatric class action re false promotion of Paxil. Judge approves final terms of improved national pediatric paxil class action settlement – consumers get a better deal.

  • Third-Party Payer Class Action $40 Million Settlement

    $40 million third-party payer class action re off-label promotion of Paxil. Judge approves $40 million settlement in the second phase of national pediatric paxil class action – insurance companies to be reimbursed.

  • Defective Drug Class Action $28 Million Settlement

    $28 million Paxil defective drug class action. A class action has been brought in the US territory of Puerto Rico against UK-based drug major GlaxoSmithKline.

  • Celexa-Lexapro Pediatric Class Action $10 Million Settlement

    $10 million pediatric class action re false promotion of Celexa and Lexapro. Babies born to women who have used Lexapro and other similar medications such as Zoloft, Celexa, Prozac, Paxil, and Symbyax are at an increased risk for birth defects.

  • Drug Injury $9 Million Settlement

    Wisner Baum obtained a $9 million settlement on behalf of an individual who was injured by a drug.

  • Pharmaceutical Settlement $105 Million Settlement

    Wisner Baum obtained $105 million on behalf of multiple clients involved in a pharmaceutical negligence case.

  • Best Law Firms 2023
    Best Law Firms 2023

    A ranking in The U.S. News – Best Lawyers® “Best Law Firms” is widely regarded by both client and legal professionals as a significant honor. It is considered the most reliable, unbiased source of legal referrals anywhere.

  • The Truck Safety Coalition
    The Truck Safety Coalition

    Wisner Baum is proud to be a sponsor of The Truck Safety Coalition, a a group of caring individuals dedicated to reducing the number of deaths and injuries caused by truck-related crashes. Our support enables them to help families and save lives.

  • California Powerhouse
    California Powerhouse

    Law360 recognizes law firms that have a strong regional presence, working on important matters within their home state. “[Wisner Baum] possesses a David v. Goliath-sized slingshot while seeking justice for everyday citizens it believes were harmed or killed through corporate wrongdoing.”

  • Elite Trial Lawyers
    Elite Trial Lawyers

    NLJ and American Lawyer Media honor law firms and attorneys as Elite Trial Lawyers for their cutting-edge legal work on behalf of plaintiffs in practice areas ranging from mass torts to securities litigation.

  • Listed in Best Lawyers
    Listed in Best Lawyers

    Best Lawyers is the oldest and most respected peer-review publication in the legal profession. A listing in Best Lawyers is widely regarded by both clients and legal professionals as a significant honor, conferred on a lawyer by his or her peers.

  • AV Top Ranked Law Firm
    AV Top Ranked Law Firm

    Less than one-half of one percent of firms across the nation have achieved this ranking. A firm must have a high percentage of lawyers who have achieved the prestigious AV® Preeminent rating by Martindale-Hubbell®.

  • Verdicts Hall of Fame
    Verdicts Hall of Fame

    The National Law Journal inducted Wisner Baum into the Verdicts Hall of Fame for obtaining the $2 billion landmark verdict in the Roundup cancer case of Pilliod et al. v. Monsanto. The verdict was #1 in California and #2 in the U.S. in 2019 and is #9 in American history.

  • Super Lawyers
    Super Lawyers

    Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement.

  • National Trial Lawyers Top 100
    National Trial Lawyers Top 100

    The National Trial Lawyers Top 100 recognized the law firms of Wisner Baum, the Miller Firm and Audet & Partners with the 2019 Trial Team of the Year award (in the Mass Torts category) for their work in the groundbreaking case of Dewayne “Lee” Johnson v. Monsanto Company.

  • AV Preeminent Peer Review Rated
    AV Preeminent Peer Review Rated

    An AV® rating reflects an attorney who has reached the heights of professional excellence. The rating signifies the highest legal ability, and very high adherence to professional standards of conduct, ethics, reliability, and diligence.

  • Avvo 10.0 Rating
    Avvo 10.0 Rating

    Wisner Baum is proud to have all of its lawyers listed in Avvo, a legal directory connecting people in need of legal services with lawyers and connecting lawyers to lawyers. Eight of our attorneys have earned a 10.0 perfect rating with Avvo.

  • Top Jury Verdict in <br> CA and USA
    Top Jury Verdict in
    CA and USA ranks our $2 billion verdict in Pilliod et al. v. Monsanto as the biggest verdict in California and the second largest verdict in the U.S. in 2019. It is the ninth largest verdict in U.S. history.

  • Lawdragon 500 Leading Plaintiff Consumer Lawyers
    Lawdragon 500 Leading Plaintiff Consumer Lawyers

    Published annually, the Lawdragon 500 Leading Plaintiff Consumer Lawyers list recognizes the “best of the best” in this area of the law through nominations, research, and review by a board of their peers.

  • Product Liability Practice Group of the Year
    Product Liability Practice Group of the Year

    In 2020, Law360 honored the law firms ”behind the litigation wins and major deals that resonated throughout the legal industry.” It recognized our success in several landmark cases.

  • Top Personal Injury Jury Verdict in California
    Top Personal Injury Jury Verdict in California

    In 2018, our $289 million Johnson v. Monsanto verdict was the largest personal injury verdict in California. also ranked it #2 among all verdicts in California and #10 in the nation.

  • Bar Register of Preeminent Lawyers
    Bar Register of Preeminent Lawyers

    The Bar Register is the definitive guide to the most distinguished law firms in America. It includes only those select law practices that have earned the highest rating in the Martindale-Hubbell Law Directory and have been designated by their colleagues as preeminent in their field.


Firm Reviews

What Our Clients Are Saying
  • I Can’t Imagine a Better Law Firm

    “Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.”

    - Best Law Firms Survey
  • They Are About Changing the Systems...

    “Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.”

    - Kim Witczak
  • Top Legal Minds in the Country

    “The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”

    - From Best Lawyers® Best Law Firms
  • Diligent & Professional Representation

    “Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.”

    - W.T.
  • Our Best Interest Was Always Number One on Your List

    “A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.”

    - G.C. & C.C